PFDD Versus PFDRT in Chiari Decompression Surgery
Launched by XUANWU HOSPITAL, BEIJING · Oct 9, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different surgical approaches for treating Chiari malformation type I, a condition where brain tissue extends into the spinal canal, often causing headaches and other symptoms. Specifically, the study will compare a surgery that involves decompressing the back of the skull and covering the area (called duraplasty) with one that also includes moving the tonsils. The goal is to see which approach leads to better recovery, fewer complications, and an improved quality of life for patients.
To participate in this trial, you need to be at least 14 years old and have a Chiari malformation with certain specific features, including a 5 mm or greater displacement of the tonsils and a type of fluid-filled cyst in the spine called syringomyelia. Before the surgery, participants will need to share MRI scans of their brain and spine. This study is open to all genders and is currently recruiting participants. If you decide to join, you can expect to undergo one of the two surgical procedures and will be monitored for improvements in your symptoms and overall well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥14 years old
- • Chiari malformation type I ≥5 mm tonsillar ectopia
- • a syrinx with a width \> 50% of the cross-sectional diameter of the spinal cord , and a length of at least 2 cervical and/or thoracic vertebral segments.
- • MRI of the brain and cervical and thoracic spine are required prior to surgery and must be available to be shared with the Data Coordinating Center
- Exclusion Criteria:
- • included one or more of the following preexisting conditions: hydrocephalus; tumor; brain trauma; stroke; meningitis; abscess;
- • other congenital anomalies of the brain or skull base; vertebral anomalies (i.e., Klippel-Feil, atlas assimilation, etc.);
- • degenerative or demyelinating disease;
- • CM-I without syringomyelia;
- • syringomyelia with cerebellar tonsils in a normal position;
- • fibromyalgia;
- • chronic fatigue syndrome;
- • prior posterior fossa surgery.
- • Unable to share pre-decompression MRI of the brain and spine Patients who do not wish to participate
About Xuanwu Hospital, Beijing
Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
fengzeng jian
Study Chair
Xuanwu Hospital, Beijing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported